Retatrutide: The Triple Agonist Retatrutide takes this approach one step further by activating three hormone receptors: GLP-1: Appetite suppression and blood sugar control GIP: Improved insulin function and fat metabolism Glucagon: Increases energy expenditure and fat burning That third targetthe glucagon receptoris what sets retatrutide apart
Semaglutide is unusual: it's on-patent, commercially available, and still legally compoundable due to shortage status
Thus roughly 40% of the total amount of weight lost on Wegovy was due to lean mass reduction
Label the vial with the compound, reconstitution date, concentration, and expiration window
The 25-mg/kg dose reduced these parameters by 48.8%, 30.3%, 33.4%, and 47.5%, respectively, while the 50-mg/kg dose showed more pronounced effects, reducing them by 67.9%, 58.6%, 60.4%, and 73.6%, respectively, in comparison with the TAA group (Figures 4AD)
doi:10.1073/pnas.1907077116